The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
The toxic effects of tumor necrosis factor in vivo and their prevention by cyclooxygenase inhibitors.
Open accessAbstract
Tumor necrosis factor (TNF) is a macrophage product under active study as an anticancer drug. However, this agent can be very toxic and has been implicated in the pathogenesis of endotoxic shock. After intravenous injection of human recombinant TNF (4 micrograms/g), growing rats showed an unusual constellation of physiological responses, and all died within 2-4 hr. In 1 hr, TNF caused a sharp fall (2.5 degrees C) in body temperature and a large increase in plasma prostaglandin E2 levels. Blood glucose initially increased, but then a profound hypoglycemia developed by 2 hr. The TNF-treated animals also showed diarrhea, cyanosis, and a severe metabolic acidosis. A single injection of the cyclooxygenase inhibitors indomethacin or ibuprofen before the TNF treatment completely prevented the rapid killing and reduced eventual lethality by 70%. These agents blocked prostaglandin E2 production and prevented the hypothermia, changes in blood glucose, acidosis, and other symptoms. Since similar physiological changes have been reported after endotoxin injection, our data support the suggestion that TNF production is a critical factor in the development of septic shock. These findings also indicate that increased production of prostaglandins or thromboxanes is important in endotoxic shock and argue that cyclooxygenase inhibitors should be useful in its therapy. Indomethacin did not block the cytotoxic effects of TNF in vitro on several transformed cell lines (HeLa, Me 180, or L929). Therefore, combined use of TNF with a cyclooxygenase inhibitor may allow safer administration of high doses of this polypeptide to cancer patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An endotoxin-induced serum factor that causes necrosis of tumors
Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., & Williamson, B. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.9.3666 · Cited by 4,532
Shock and Tissue Injury Induced by Recombinant Human Cachectin
Tracey, K. J., Beutler, B., Lowry, S. F., Merryweather, J., Wolpe, S., Milsark, I. W., Hariri, R. J., Fahey, T. J., Zentella, A., Albert, J. D., et al. (1986) · Science · doi:10.1126/science.3764421 · Cited by 2,549
Beutler, B., Milsark, I. W., & Cerami, A. C. (1985) · Science · doi:10.1126/science.3895437 · Cited by 2,352
Old, L. J. (1985) · Science · doi:10.1126/science.2413547 · Cited by 1,895
Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin
Pennica, D., Nedwin, G. E., Hayflick, J. S., Seeburg, P. H., Derynck, R., Palladino, M. A., Kohr, W. J., Aggarwal, B. B., & Goeddel, D. V. (1984) · Nature · doi:10.1038/312724a0 · Cited by 1,736
Cachectin and tumour necrosis factor as two sides of the same biological coin
Beutler, B., & Cerami, A. (1986) · Nature · doi:10.1038/320584a0 · Cited by 1,647
Dinarello, C. A. (1984) · Clinical Infectious Diseases · doi:10.1093/clinids/6.1.51 · Cited by 1,644
Sugarman, B. J., Aggarwal, B. B., Hass, P. E., Figari, I. S., Palladino, M. A., & Shepard, H. M. (1985) · Science · doi:10.1126/science.3933111 · Cited by 1,580
Dayer, J. M., Beutler, B., & Cerami, A. (1985) · The Journal of experimental medicine · doi:10.1084/jem.162.6.2163 · Cited by 1,216
Identity of tumour necrosis factor and the macrophage-secreted factor cachectin
Beutler, B., Greenwald, D., Hulmes, J. D., Chang, M., Pan, Y.-C. E., Mathison, J., Ulevitch, R., & Cerami, A. (1985) · Nature · doi:10.1038/316552a0 · Cited by 1,131
Characterization of receptors for human tumour necrosis factor and their regulation by γ-interferon
Aggarwal, B. B., Eessalu, T. E., & Hass, P. E. (1985) · Nature · doi:10.1038/318665a0 · Cited by 884
Beutler, B., Mahoney, J., Le Trang, N., Pekala, P., & Cerami, A. (1985) · The Journal of experimental medicine · doi:10.1084/jem.161.5.984 · Cited by 821
Philip, R., & Epstein, L. B. (1986) · Nature · doi:10.1038/323086a0 · Cited by 767
Baracos, V., Rodemann, H. P., Dinarello, C. A., & Goldberg, A. L. (1983) · New England Journal of Medicine · doi:10.1056/nejm198303103081002 · Cited by 690
Self-citationMolecular Cloning of the Complementary DNA for Human Tumor Necrosis Factor
Wang, A. M., Creasey, A. A., Ladner, M. B., Lin, L. S., Strickler, J., Van Arsdell, J. N., Yamamoto, R., & Mark, D. F. (1985) · Science · doi:10.1126/science.3856324 · Cited by 622
A Macrophage Factor Inhibits Adipocyte Gene Expression: An in Vitro Model of Cachexia
Torti, F. M., Dieckmann, B., Beutler, B., Cerami, A., & Ringold, G. M. (1985) · Science · doi:10.1126/science.3839597 · Cited by 518
Cloning and expression in Escherichia coli of the gene for human tumour necrosis factor
Shirai, T., Yamaguchi, H., Ito, H., Todd, C. W., & Wallace, R. B. (1985) · Nature · doi:10.1038/313803a0 · Cited by 459
Williamson, B. D., Carswell, E. A., Rubin, B. Y., Prendergast, J. S., & Old, L. J. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.17.5397 · Cited by 456
Induction of the synthesis of tumor necrosis factor receptors by interferon-gamma.
Ruggiero, V, Tavernier, J., Fiers, W., & Baglioni, C. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.7.2445 · Cited by 318
Self-citationHaranaka, K., Satomi, N., & Sakurai, A. (1984) · International Journal of Cancer · doi:10.1002/ijc.2910340219 · Cited by 311
Fransen, L., van der Heyden, J., Ruysschaert, R., & Fiers, W. (1986) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(86)90107-0 · Cited by 281
Self-citationMARMENOUT, A., FRANSEN, L., TAVERNIER, J., VAN DER HEYDEN, J., TIZARD, R., KAWASHIMA, E., SHAW, A., JOHNSON, M., SEMON, D., MÜLLER, R., et al. (1985) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1985.tb09226.x · Cited by 239
Self-citationEffect of tumour necrosis factor on cultured human melanoma cells
HELSON, L., GREEN, S., CARSWELL, E., & OLD, L. J. (1975) · Nature · doi:10.1038/258731a0 · Cited by 238
Balkwill, F. R., Lee, A., Aldam, G., Moodie, E. M., Thomas, J. A., Tavernier, J. H., & Fiers, W. (1986) · PubMed · Cited by 211
Self-citationCerami, A., Ikeda, Y., Le Trang, N., Hotez, P. J., & Beutler, B. (1985) · Immunology Letters · doi:10.1016/0165-2478(85)90165-8 · Cited by 202
Brouckaert, P. G. G., Leroux‐Roels, G. G., Guisez, Y., Tavernier, J., & Fiers, W. (1986) · International Journal of Cancer · doi:10.1002/ijc.2910380521 · Cited by 177
Self-citationPulmonary injury and prostaglandin production during endotoxemia in conscious sheep
Demling, R. H., Smith, M., Gunther, R., Flynn, J. T., & Gee, M. H. (1981) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1981.240.3.h348 · Cited by 159
Low concentrations of indomethacin inhibit phospholipase A2 of rabbit polymorphonuclear leukocytes.
Kaplan, L., Weiss, J. P., & Elsbach, P. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.6.2955 · Cited by 157
Bernheim, H. A., Gilbert, T. M., & Stitt, J. T. (1980) · The Journal of Physiology · doi:10.1113/jphysiol.1980.sp013189 · Cited by 136
Ibuprofen in canine endotoxin shock.
Jacobs, E. R., Soulsby, M., Bone, R. C., Wilson, F. J., & Hiller, F. C. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110645 · Cited by 129
The physiologic, metabolic, and immunologic actions of interleukin-1
Borek, F. (1987) · Journal of Immunological Methods · doi:10.1016/0022-1759(87)90141-4 · Cited by 127
Mediation of mouse natural cytotoxic activity by tumour necrosis factor
Ortaldo, J. R., Mason, L. H., Mathieson, B. J., et al. (1986) · Nature · doi:10.1038/321700a0 · Cited by 116
The stability of 13,14-dihydro-15 keto-PGE2
Fitzpatrick, F. A., Aguirre, R., Pike, J. E., & Lincoln, F. H. (1980) · Prostaglandins · doi:10.1016/0090-6980(80)90126-4 · Cited by 91
Tumor necrosis factor receptors in HeLa cells and their regulation by interferon-gamma.
Tsujimoto, M., & Vilček, J. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)57227-1 · Cited by 84
Insulin hypersecretion and potentiation of endotoxin shock in the rat.
Yelich, M. R., & Filkins, J. P. (1982) · PubMed · Cited by 22
Treatment of experimental canine endotoxin shock with ibuprofen, a cyclooxygenase inhibitor.
Pm, A., KUENZIG, M. C., & Schwartz, S. I. (1984) · PubMed · Cited by 21
Implications for thromboxane A2 in the pathogenesis of endotoxic shock.
Wise, W. C., Cook, J. A., & Halushka, P. V. (1981) · PubMed · Cited by 19
Cited by
Tumour necrosis factor and cancer
Balkwill, F. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2628 · Cited by 1,915
Muscle wasting in disease: molecular mechanisms and promising therapies
Cohen, S., Nathan, J. A., & Goldberg, A. L. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4467 · Cited by 1,089
Self-citationTumor necrosis factor: a pleiotropic cytokine and therapuetic target
Tracey, M. D., & Cerami, P. D. (1994) · Annual Review of Medicine · doi:10.1146/annurev.med.45.1.491 · Cited by 1,063
Tumor Necrosis Factor and Disease Severity in Children with Falciparum Malaria
Grau, G. E., Taylor, T. E., Molyneux, M. E., Wirima, J. J., Vassalli, P., Hommel, M., & Lambert, P.-H. (1989) · New England Journal of Medicine · doi:10.1056/nejm198906153202404 · Cited by 842
Wong, G. H. W., Elwell, J. H., Oberley, L. W., & Goeddel, D. V. (1989) · Cell · doi:10.1016/0092-8674(89)90944-6 · Cited by 802
Metadata
- Authors
- Kettelhut, I. C., Fiers, W., & Goldberg, A. L.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1987-06
- Volume
- 84
- Issue
- 12
- Pages
- 4273-4277
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2091309369
- Cited by
- 286
- References
- 37
- FWCI
- 34.61
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.